New drug for a diagnosis of rheumatoid arthritis shows earnest success

    These tabs need JavaScript to be enabled.

    Baricitinib in Patients with Refractory Rheumatoid Arthritis, Mark C. Genovese, M.D., Joel Kremer, M.D., Omid Zamani, M.D., Charles Ludivico, M.D., Marek Krogulec, M.D., Li Xie, M.S., Scott D. Beattie, Ph.D., Alisa E. Koch, M.D., Tracy E. Cardillo, M.S., Terence P. Rooney, M.D., William L. Macias, M.D., Ph.D., Stephanie de Bono, M.D., Ph.D., Douglas E. Schlichting, M.S., and Josef S. Smolen, M.D., New England Journal of Medicine, doi: 10.1056/NEJMoa1507247, published 31 Mar 2016.

    Source: Medical University of Vienna

Article Original Source: Click here for details

Related Posts